UnknownPhase 2NCT04313036

5-day Defibrotide Treatment for Hepatic SOS/VOD

Studying Hepatic veno-occlusive disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Loyola University
Principal Investigator: Patrick A Hagen, MD
Loyola University
Intervention: Defibrotide(drug)
Enrollment: 24 target
Eligibility: 18 years · All sexes
Timeline: 2021 – 2022

Study locations (1)

Loyola University Medical Center, Maywood, Illinois, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04313036 on ClinicalTrials.gov

Other trials for Hepatic veno-occlusive disease

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT05987124
Defibrotide Dose-escalation for SOS Post-HSCT
New York Medical College
RECRUITINGNCT06715046
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation
University of Turin, Italy
RECRUITINGNCT05090345
A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
Duke University
ACTIVE NOT RECRUITINGNANCT03865589
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
Children's Mercy Hospital Kansas City

See all trials for Hepatic veno-occlusive disease →

← Back to all trials